Business Context and Reporting Period
This Form 8-K Current Report, filed on April 7, 2025, covers events occurring on April 1, 2025, for Healthcare Realty Trust Incorporated. The filing primarily addresses significant changes in executive leadership, specifically the appointment of a new President and Chief Executive Officer (CEO) and the departure of the interim CEO.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data contained within this document is limited to the compensation package for the newly appointed CEO, Peter A. Scott:
- Base Salary: $750,000 per year.
- Annual Cash Incentive Target: $1,350,000 (180% of base salary).
- 2025 Equity Incentives: $3,900,000 target value (comprising $2,730,000 in performance-based LTIP Units and $1,170,000 in retention-based restricted stock).
- One-Time Restricted Stock Award: $5,750,000 grant date value, vesting over four years.
- Relocation Benefits: $400,000.
Material Changes Versus Prior Period
The primary material change reported is the transition of executive leadership:
- Appointment: Peter A. Scott was appointed President and CEO, effective April 15, 2025. He previously served as CFO of Healthpeak Properties, Inc.
- Departure: Constance B. Moore stepped down as Interim President and CEO concurrent with Mr. Scott's appointment.
- Transition Arrangement: Ms. Moore will remain in a transition role for up to 60 days at a monthly salary of $90,000 and will continue to serve on the Board of Directors.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding the company's operational performance. Key contractual terms and risks related to the new CEO's employment include:
- Severance Provisions:
- Termination without cause: 2x base salary plus 2x bonus (greater of average or target), plus pro-rated bonus and accelerated vesting of time-based equity.
- Change in Control: 3x base salary plus 3x bonus, plus pro-rated bonus and accelerated vesting of time-based equity. Performance-based equity is deemed earned at the greater of target or actual performance.
- Restrictive Covenants: Mr. Scott is subject to non-compete restrictions during employment and for one year following a termination in connection with a change-in-control or other than for cause.
- Board Membership: Mr. Scott is expected to join the Board of Directors following the 2025 annual meeting of stockholders.
Important Facts for Investor Verification
- Verify the full text of the Employment Agreement, which will be filed as an exhibit to the Form 10-Q for the quarter ended March 31, 2025.
- Review the definitive Proxy Statement (Schedule 14A) for the 2025 Annual Meeting for details on Mr. Scott's potential election to the Board and other governance matters.
- Confirm the vesting schedule and performance metrics for the $2,730,000 LTIP Units, which are linked to relative total shareholder return against a healthcare REIT peer group and the MSCI US REIT Index.
- Note that the filing explicitly states it does not contain financial results; investors should refer to the most recent Form 10-K or 10-Q for operational data.